Navigation Links
Understanding The Predictors Of Prostate Cancer

A new study could change the way doctors treat certain prostate cancer patients.The three strongest predictors for the outcome for a prostate cancer patient are grade, PSA level and pathologic stage. //The summation of these three predictors is what determines the Gleason grading system or a Gleason score (GS). The most common Gleason score among patients with prostate cancer is seven. In a new study, researchers look to understand the prognosis of patients with a score of seven.

Researchers studied 412 patients with tumors that measured a Gleason score of seven and were treated with radical prostatectomy. They looked at the patient outcomes based on their Gleason pattern (GP). Different Gleason patterns of the tumor also help determine the Gleason score.

In the study group, researchers say 307 patients had primary GP three tumors, 105 patients had primary GP four tumors, and 17 had GP five tumors. Researchers found those with GP five had significantly shorter times to disease recurrence. Researchers also say patients with GP four and GP five had a higher risk for disease recurrence.

Researchers thus conclude when looking at Gleason scores of seven, those patients with GP four tumors are at risk for a more aggressive cancer. They say looking at the primary GP is easily accessible and clinically relevant predictor of disease recurrence in patients with GS seven prostate cancer. They hope this will help doctors in the management of patients with GS seven prostate cancer.


'"/>




Page: 1

Related medicine news :

1. Understanding Restless Legs Syndrome
2. Understanding Lung Cancer Metastasis
3. Understanding The Link Between Hormone Replacement and Respiratory Disease
4. Understanding The Risks Of Hormone Therapy
5. Understanding The Link Between Metabolic Syndrome And Drinking Patterns
6. A Better Understanding Of The Brain Network
7. Understanding The Predictor’s Of Alzheimer’s Diseae
8. Understanding The Harmful Effects Of Radiation Exposure
9. Understanding The Origin Of Tumors
10. Understanding Insulin Resistance
11. Understanding The Link Between Phobias And Fatal Heart Disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:1/20/2017)... FL (PRWEB) , ... January 20, 2017 , ... Source ... botanicals and 100 percent pure essential oils, announced the company had a successful visit ... , The annual ECRM event gives companies that work in the nutritional, sports and ...
(Date:1/20/2017)... ... 20, 2017 , ... International Protein, a company based out of Australia that ... the January ECRM trade show in Hilton Head, SC. , International Protein was ... create a line of products that would elevate her fitness regime. At this ECRM ...
(Date:1/20/2017)... ... January 20, 2017 , ... “The Angel”: a ... has set out for each of his children. “The Angel” is the creation of ... Music in New York City, and impassioned writer. , When asked of her new ...
(Date:1/20/2017)... ... ... “Journey to Christmas:” a beautiful and enchanting tale that teaches children the true meaning of ... three in Oklahoma City, and a devoted woman of faith. , “Becoming a parent ... the back of my mind for years, but actually doing it might have been a ...
(Date:1/19/2017)... ... January 19, 2017 , ... ... E-learning system for Clinical and Regulatory education for Physicians, Physician Advisors, Case ... successful education methodology of Disease Specific Documentation Improvement. , The Aerolib Learning ...
Breaking Medicine News(10 mins):
(Date:1/19/2017)... , Jan. 19, 2017  Sensus Healthcare, Inc. ... company specializing in the treatment of non-melanoma skin ... with superficial radiation therapy, today announced that it ... 2016 financial results on Thursday, February 2, 2017 after ... hold a conference call with the investment community ...
(Date:1/19/2017)... England , January 19, 2017 ... and Otsuka in the Milner Therapeutics Consortium   ... scientists in Cambridge   ... (NYSE: PFE ) as a partner to ... the Consortium, which enables the efficient transfer of materials ...
(Date:1/19/2017)... 18, 2017 , , Marks E-QURE ... distribution agreement, following similar agreements in Israel ... care is $2 5 billion global ... Corp. (OTCQB: EQUR), a leader in medical devices for the treatment of advanced ... Equipos Médicos S.A.S. (TeckMedica) in Colombia for the Company,s ...
Breaking Medicine Technology: